Cargando…
Melanoma Expressed-CD70 Is Regulated by RhoA and MAPK Pathways without Affecting Vemurafenib Treatment Activity
CD70 is a costimulatory molecule member of the Tumor Necrosis Factor family that is expressed on activated immune cells. Its ectopic expression has been described in several types of cancer cells including lymphomas, renal cell carcinomas and glioblastomas. We have recently described its expression...
Autores principales: | Pich, Christine, Teiti, Iotefa, Sarrabayrouse, Guillaume, Gallardo, Franck, Gence, Rémi, Tilkin-Mariamé, Anne-Françoise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734704/ https://www.ncbi.nlm.nih.gov/pubmed/26828592 http://dx.doi.org/10.1371/journal.pone.0148095 |
Ejemplares similares
-
Melanoma-expressed CD70 is involved in invasion and metastasis
por: Pich, Christine, et al.
Publicado: (2016) -
In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression
por: Teiti, Iotefa, et al.
Publicado: (2015) -
Statins Reduce Melanoma Development and Metastasis through MICA Overexpression
por: Pich, Christine, et al.
Publicado: (2013) -
Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth
por: Gallardo, Franck, et al.
Publicado: (2018) -
Melanoma Cells Treated with GGTI and IFN-γ Allow Murine Vaccination and Enhance Cytotoxic Response against Human Melanoma Cells
por: Sarrabayrouse, Guillaume, et al.
Publicado: (2010)